In addition, we revealed that NRF1 is the key molecular mediator in this process and that IL-17A could enhance the expression of PD-L1 in CRC cells through the P65/NRF1/miR-15b-5p axis. The gene discussed is NRF1; the disease is colorectal carcinoma.